546.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
MDGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Toth Financial Advisory Corp Makes New $1.17 Million Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals Grants Equity Awards to New Employees Under 2025 Inducement Plan - MSN
MDGL stock surges most in a month on Eli Lilly buyout speculation - MSN
What makes Madrigal Pharma (MDGL) one of the shorted biotech stocks to buy - MSN
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Madrigal Pharmaceuticals to Present at Morgan Stanley Global Health Care Conference - MSN
Madrigal grants equity awards to seven new employees - MSN
Barclays Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $964 - moomoo.com
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step - Benzinga
Why Madrigal Pharmaceuticals (MDGL) Is Up 14.1% After Expanding Its MASH Franchise Beyond Rezdiffra - Sahm
Madrigal Soars 5.87% on Strong Analyst Momentum and Institutional Shifts—Where to Now? - bitget.com
Hennion & Walsh Asset Management Inc. Sells 4,684 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
MDGL Technical Analysis | Trend, Signals & Chart Patterns | MADRIGAL PHARMACEUTICALS INC (NASDAQ:MDGL) - ChartMill
Understanding Momentum Shifts in (MDGL) - Stock Traders Daily
Madrigal Pharmaceuticals grants equity awards to 20 new employees - MSN
Madrigal Pharmaceuticals (MDGL) surged on strong sales of its Rezdiffra drug - MSN
Assenagon Asset Management S.A. Acquires New Stake in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals stock dips after team presence at Liver Connect Conference sees doubled attendance - Traders Union
Madrigal Reports $212.8M in Q2 Rezdiffra Sales, Expands Global Pipeline and Secures $500M Financing - MSN
Loss Report: What are analysts price targets for Madrigal Pharmaceuticals Inc2026 Bull vs Bear & Technical Pattern Based Signals - baoquankhu1.vn
MDGL Stock Surges Most In A Month On Eli Lilly Buyout Speculation - Stocktwits
Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug - Insider Monkey
Vanguard (MDGL) files amendment; reports 0 shares after Jan 12, 2026 realignment - Stock Titan
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains? - Yahoo Finance
Is It Too Late To Consider Madrigal Pharmaceuticals (MDGL) After Recent Share Price Surge? - Yahoo Finance
Madrigal Pharmaceuticals gains amid renewed takeover speculation - MSN
Rezdiffra Shows Promise as Madrigal’s Liver Drug Garners Positive Results - StocksToTrade
Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading 11.7% HigherShould You Buy? - marketbeat.com
Madrigal Surges 11.66%: A Volatile Breakout Defies Sector Stagnation as Bulls Test $572 - Bitget
Madrigal Grants Equity Awards to Seven New Employees - MyChesCo
Madrigal Pharmaceuticals, Inc. $MDGL Stock Position Raised by Peak Financial Advisors LLC - MarketBeat
Fundamentals Check: Is Madrigal Pharmaceuticals Inc benefiting from innovation trends2026 Momentum & Consistent Return Strategy Ideas - baoquankhu1.vn
JPMorgan Chase & Co. Sells 8,030 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Aug Selloffs: How correlated is Madrigal Pharmaceuticals Inc to the S P5002026 Price Momentum & AI Powered Market Trend Analysis - baoquankhu1.vn
Madrigal outlines robust 2026 net sales growth and expanding pipeline amid 50% MASH market surge - MSN
Madrigal slides more than 5% as wider Q4 loss tempers strong sales growth - MSN
Madrigal inks licensing deal with China’s Suzhou Ribo for MASH drugs - MSN
Madrigal grants inducement awards to five employees - MSN
Madrigal Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Avoiding Lag: Real-Time Signals in (MDGL) Movement - Stock Traders Daily
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Groupama Asset Managment Sells 13,447 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):